Lakewood-Amedex Starts Phase 2a Trial of Nu-3 for Foot Ulcers
San Diego, California, U.S., September 24, 2026 Lakewood-Amedex Biotherapeutics has announced that the first patient has been dosed in...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
San Diego, California, U.S., September 24, 2026 Lakewood-Amedex Biotherapeutics has announced that the first patient has been dosed in...
